InvestSMART

Genetic Signatures Limited (ASX: GSS) - Announcements

- Current share price for GSS : $0.058

ASX company news and announcements for Genetic Signatures Limited (GSS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Signatures Limited (GSS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Signatures Limited (GSS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Signatures Limited (GSS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13 AGM Results of Meeting 20 Nov 2024 2:24PM $0.700 $0.058 fallen by 91.71%
$13 2024 AGM Chairman's Address and CEO Presentation 20 Nov 2024 8:20AM $0.720 $0.058 fallen by 91.94%
$13 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2024 8:41AM $0.620 $0.058 fallen by 90.65%
$13 Notice of Annual General Meeting/Proxy Form 18 Oct 2024 4:02PM $0.655 $0.058 fallen by 91.15%
$13 Notification regarding unquoted securities - GSS 14 Oct 2024 8:29AM $0.580 $0.058 fallen by 90%
$13 Initial Director's Interest Notice - Jenny Harry 1 Oct 2024 8:44AM $0.665 $0.058 fallen by 91.28%
$13 Initial Director's Interest Notice - Anne Lockwood 1 Oct 2024 8:40AM $0.665 $0.058 fallen by 91.28%
$13 Final Director's Interest Notice 20 Sep 2024 8:40AM $0.685 $0.058 fallen by 91.53%
$13 Board Composition Update 20 Sep 2024 8:25AM $0.685 $0.058 fallen by 91.53%
$13 Becoming a substantial holder 18 Sep 2024 4:06PM $0.688 $0.058 fallen by 91.56%
$13 Notification of cessation of securities - GSS 5 Sep 2024 1:43PM $0.715 $0.058 fallen by 91.89%
$13 Application for quotation of securities - GSS 5 Sep 2024 1:27PM $0.715 $0.058 fallen by 91.89%
$13 Appendix 4G and Corporate Governance Statement 30 Aug 2024 2:25PM $0.750 $0.058 fallen by 92.27%
$13 Appendix 4E and Annual Report 30 Aug 2024 2:03PM $0.740 $0.058 fallen by 92.16%
$13 Final Director's Interest Notice 22 Aug 2024 4:58PM $0.705 $0.058 fallen by 91.77%
$13 Changes to Genetic Signatures' Board of Directors 22 Aug 2024 2:01PM $0.700 $0.058 fallen by 91.71%
$13 Notification of cessation of securities - GSS 5 Aug 2024 2:16PM $0.770 $0.058 fallen by 92.47%
$13 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2024 8:17AM $0.770 $0.058 fallen by 92.47%
$13 Change in substantial holding 9 Jul 2024 3:18PM $0.705 $0.058 fallen by 91.77%
$13 Change of Director's Interest Notice - C Waldron 8 Jul 2024 5:14PM n/a $0.058 n/a
$13 Change of Director's Interest Notice - S Chatonsky 8 Jul 2024 5:13PM n/a $0.058 n/a
$13 Change of Director's Interest Notice - T Radford 8 Jul 2024 5:12PM n/a $0.058 n/a
$13 Application for quotation of securities - GSS 8 Jul 2024 10:04AM n/a $0.058 n/a
$13 Change of Director's Interest Notice 5 Jul 2024 8:23AM n/a $0.058 n/a
$13 Completion of Underwritten Retail Entitlement Offer 4 Jul 2024 3:54PM n/a $0.058 n/a

76 - 100 of 504 results

Page 4 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.